Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,848 | 2,040 | 3,020 | 2,380 | 3,317 |
| TOTAL | $16,545 | $2,283 | $3,636 | $3,225 | $4,165 |
| Non-Current Assets | |||||
| PPE Net | 17 | N/A | N/A | N/A | N/A |
| Intangibles | 77,523 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 224 | 0 | 0 | 0 | 0 |
| TOTAL | $77,764 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $94,308 | $2,283 | $3,636 | $3,225 | $4,165 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,232 | 455 | 218 | 197 | 112 |
| Accrued Expenses | 1,895 | 879 | 282 | 373 | 247 |
| TOTAL | $3,176 | $1,334 | $500 | $570 | $359 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,381 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 155 | 0 | 0 | 0 | 0 |
| TOTAL | $26,851 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $30,027 | $1,334 | $500 | $570 | $359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,911 | 1,332 | 1,110 | 770 | 770 |
| Common Shares | 0 | 0 | 3 | 2 | 0 |
| Retained earnings | -73,819 | -66,091 | -63,810 | -62,761 | -61,469 |
| Other shareholders' equity | 70,243 | -299 | -299 | -299 | -299 |
| TOTAL | $64,281 | $949 | $3,136 | $2,655 | $3,807 |
| Total Liabilities And Equity | $94,308 | $2,283 | $3,636 | $3,225 | $4,165 |